Biovista
PrivateLast Round
Grant
Mar 6, 2012
Total Funding Raised
$500,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Biovista operates in Healthcare & Life Sciences and is based in Charlottesville, Virginia. Its latest recorded funding round was a Grant round in March 2012.
Biovista is a biotechnology company that has developed an artificial intelligence-based platform intended to deliver custom drug repositioning, drug de-risking, and clinical hold services for the biopharma industry.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts, Subscription SaaS, Data as a Service, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biovista Comparables
Compare Biovista with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Delta4 | 90% | |
| Purposeful | 84% | |
| Healx | 80% |
For institutional investors. Book with your work email.
Biovista Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 6, 2012 | ||||
| Grant | May 5, 2011 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Biovista Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Solve ME/CFS Initiative | Grant |
| European Union Seventh Framework Programme | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 30% MoM.
- Jun 25, 2026
Monthly visitors increased 123% MoM, reaching 4.8K.
For institutional investors. Book with your work email.
Biovista Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biovista's valuation, stock price, and market status.
Is Biovista a public or private company?
Biovista is a private company.
What is the current stock price of Biovista?
Biovista is a private company, so its shares have no public market price. Caplight tracks Biovista's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biovista worth (valuation)?
Valuation information for Biovista is not publicly available.
Can I buy Biovista stock?
Biovista shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biovista's last funding round?
Biovista's most recent funding round was Grant on March 6, 2012.
Who are the main investors in Biovista?
Key investors in Biovista include Solve ME/CFS Initiative, European Union Seventh Framework Programme.
Will Biovista IPO soon?
No public IPO plans have been announced for Biovista.
How can I track Biovista secondary market activity?
Caplight tracks bids, offers, and trades in Biovista's shares on secondary markets.